SCHEMBL28469779

SCHEMBL28469779

CCCCCC(C)C(C)(C(=O)O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
CNR2 P34972 1/20 0.42
PRSS1 P07477 2/20 0.42
CTSG P08311 2/20 0.42
CTRB1 P17538 2/20 0.42
CMA1 P23946 2/20 0.42
MMP2 P08253 3/20 0.40
MMP3 P08254 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CTSK P43235 2/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSH P09668 1/20 0.40
CTSS P25774 1/20 0.40
HDAC8 Q9BY41 4/20 0.39
HDAC3 O15379 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
MMP9 P14780 1/20 0.39
MMP12 P39900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20986026 0.89 CYP2D6 (0.43) ALDH1A1CNR2PRSS1CTSGCTRB1
SCHEMBL8489187 0.88 MAPT (0.45) ALDH1A1CNR2PRSS1CTSGCTRB1
SCHEMBL9781115 0.83 PRSS1 (0.43) ALDH1A1CNR2PRSS1CTSGCTRB1
SCHEMBL3159723 0.82 KIF11 (0.48) ALDH1A1CYP1A2CYP2D6HDAC8HDAC3
SCHEMBL7095480 0.81 TBXAS1 (0.44) ALDH1A1CNR2MMP2MMP3CYP1A2
SCHEMBL10424312 0.81 MMP2 (0.44) ALDH1A1PRSS1CTSGCTRB1CMA1
SCHEMBL29010721 0.80 LMNA (0.39) ALDH1A1CNR2PRSS1CTSGCTRB1
SCHEMBL28727454 0.80 KIF11 (0.47) ALDH1A1CYP1A2CYP2D6HDAC8HDAC3
SCHEMBL29010715 0.80 ALDH1A1 (0.42) ALDH1A1CNR2PRSS1CTSGCTRB1
SCHEMBL27561773 0.79 ALDH1A1 (0.44) ALDH1A1CNR2PRSS1CTSGCTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111655680-B Hormone receptor modulators for the treatment of metabolic mutations and fibrotic conditions and disorders 阿德利克斯股份有限公司 2024-03-05 CN claimed
CN-110177783-B Hormone receptor modulators for the treatment of metabolic conditions and disorders 阿德利克斯股份有限公司 2023-06-06 CN claimed
CN-111655680-A Hormone receptor modulators for the treatment of metabolic mutations and fibrotic conditions and disorders 阿德利克斯股份有限公司 2020-09-11 CN claimed
CN-111655680-B Hormone receptor modulators for the treatment of metabolic mutations and fibrotic conditions and disorders 阿德利克斯股份有限公司 2024-03-05 CN disclosed
CN-116854681-A Hormone receptor modulators for the treatment of metabolic conditions and disorders 阿德利克斯股份有限公司 2023-10-10 CN disclosed
CN-110177783-B Hormone receptor modulators for the treatment of metabolic conditions and disorders 阿德利克斯股份有限公司 2023-06-06 CN disclosed
CN-112469439-A With leukotriene A4Hydrolase modulators for the treatment of aging-related diseases 万能溶剂有限公司 2021-03-09 CN disclosed
CN-111655680-A Hormone receptor modulators for the treatment of metabolic mutations and fibrotic conditions and disorders 阿德利克斯股份有限公司 2020-09-11 CN disclosed